Abstract
IT has been suggested that mutations within immunodominant cytotoxic T-lymphocyte (CTL) epitopes may be exploited by viruses to evade protective immune responses critical for clearance1–4. Viral escape could originate from passive mechanisms, such as mutations within crucial CTL epitopes, either affecting major histocompatibility complex binding or T-cell antigen receptor (TCR) recognition. Additionally, it has recently been shown that substitutions of TCR contact sites can yield analogue peptides that can still interact with the T-cell receptor but be unable to deliver a full stimulatory signal, thus inducing anergy5 or acting as an antagonist for the TCR6–8. We report here that hepatitis B virus isolates derived from two chronically infected patients display variant epitopes that act as natural TCR antagonists with the capacity to inhibit the CTL response to the wild-type epitope. During natural infection, TCR antagonist mutations of CTL epitopes could contribute to the development of viral persistence, especially if the antiviral CTL response is monospecific or the epitope is strongly immunodominant.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pircher, H. et al. Nature 346, 629–633 (1990).
Phillips, R. E. et al. Nature 354, 453–459 (1991).
de Campos-Lima, P. O. et al. Science 260, 98–100 (1993).
McMichael, A. J. Science 260, 1771–1772 (1993).
Sloan-Lancaster, J., Evavold, B. D. & Allen, P. M. Nature 363, 156–159 (1993).
De Magistris, M. T. et al. Cell 68, 625–634 (1992).
Racioppi, L., Ronchese, F., Matis, L. A. & Germain, R. N. J. exp. Med. 177, 1047–1060 (1993).
Jameson, S. C., Carbone, F. R. & Bevan, M. J. J. exp. Med. 177, 1541–1550 (1993).
Bertoletti, A. et al. J. Virol. 67, 2376–2380 (1993).
Missale, G. et al. J. exp. Med. 177, 751–762 (1993).
Nayersina, R. et al. J. Immun. 150, 4659–4671 (1993).
Penna, A. et al. J. exp. Med. 174, 1565–1569 (1990).
Bertoletti, A. et al. Proc. natn. Acad. Sci. U.S.A. 88, 10445–10449 (1990).
Hunt, D. F. et al. Science 255, 1261–1263 (1992).
Falk, K. et al. J. exp. Med. 174, 425–434 (1991).
Christinck, E. R., Luscher, M. A., Barber, B. H. & Williams, D. B. Nature 352, 67–70 (1991).
Ruppert, J. et al. Proc. natn. Acad. Sci. U.S.A. 90, 2671–2675 (1993).
Guilhot, S. et al. J. Virol. 66, 2670–2678 (1992).
Ando, K. et al. J. exp. Med. 178, 1541–1554 (1993).
Brown, J. H. et al. Nature 364, 33–39 (1993).
Pleogh, H. & Benaroch, P. Nature 364, 16–17 (1993).
Symer, D. E., Dintzis, R. Z., Diamond, D. J. & Dintzis, H. M. J. exp. Med. 176, 1421–1430 (1992).
Sette, A. et al. Molec. Immun. (in the press).
Korba, B. E. et al. J. Virol. 61, 1318–1324 (1987).
Tuttleman, J., Pourcel, C. & Summers, J. Cell 47, 451–460 (1986).
Hu, W.-S. & Temin, H. M. Science 250, 1227–1233 (1990).
Houghton, M. et al. Hepatology 14, 381–388 (1991).
Galibert, F. et al. Nature 281, 646–648 (1979).
Ruppert, J. et al. Cell 74, 1–20 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bertoletti, A., Sette, A., Chisari, F. et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369, 407–410 (1994). https://doi.org/10.1038/369407a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/369407a0
This article is cited by
-
Immunobiology and pathogenesis of hepatitis B virus infection
Nature Reviews Immunology (2022)
-
CD8+ T cells cure without killing
Nature Reviews Immunology (2019)
-
Restoring, releasing or replacing adaptive immunity in chronic hepatitis B
Nature Reviews Gastroenterology & Hepatology (2019)
-
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
Nature Medicine (2013)
-
T-cell responses in hepatitis B and C virus infection: similarities and differences
Emerging Microbes & Infections (2013)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.